Clene Inc. (CLNN)
Clene Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Clene Inc. (CLNN) is a Biotechnology company based in US with a market capitalization of $60.3M. Revenue declined 41.5% year-over-year and free cash flow was negative at -$18.6M. This page tracks CLNN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 75 employees · IPO Oct 18, 2018
Valuation
Valuation & price
$7.14as of May 17, 2026· -42.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$60.3M
Market cap
-41.5%
Revenue growth (YoY)
78.5%
Gross margin
-$18.6M
Free cash flow (USD)
$16.5M
Net debt
41.8%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
3
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $-0.31)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventMay 22, 2026Filing
Stock Plan Amendment
- Quarterly reportMay 14, 2026Filing
10-Q Filed
- 8-K eventMay 14, 2026Filing
Earnings Release
- Insider sellMay 13, 2026Filing
Insider Sell $604KUgwumba Chidozie · 10% Owner · $604.1K
- Insider sellMay 5, 2026Filing
Insider Sell $530KUgwumba Chidozie · 10% Owner · $530.4K
- 8-K eventMay 5, 2026Filing
Common Stock Offering
- 8-K eventMay 4, 2026Filing
NDA Filing Announcement
- Insider sellApr 30, 2026Filing
Insider Sell $113KUgwumba Chidozie · 10% Owner · $112.8K
- Insider sellApr 22, 2026Filing
Insider Sell $403KUgwumba Chidozie · 10% Owner · $403.1K
- Insider sellApr 17, 2026Filing
Insider Sell $252KUgwumba Chidozie · 10% Owner · $251.9K
Questions
Frequently asked questions
What is Clene Inc.'s market cap?
Clene Inc. (CLNN) has a market capitalization of $60.3M.
What is CLNN's P/E ratio?
A meaningful P/E ratio is not available for CLNN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did Clene Inc. last report earnings?
CLNN last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying CLNN stock?
SEC Form 4 filings show no open-market insider buys at Clene Inc. in the last 90 days (3 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.